Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.53
-0.35 (-5.09%)
At close: Mar 28, 2025, 4:00 PM
6.69
+0.16 (2.45%)
After-hours: Mar 28, 2025, 6:36 PM EDT
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $38.26 million as of March 28, 2025. Its market cap has decreased by -43.74% in one year.
Market Cap
38.26M
Enterprise Value
41.19M
1-Year Change
-43.74%
Ranking
Category
Stock Price
$6.53
Market Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $38.26M, a decrease of -82.23%. That is a compound annual growth rate of -15.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 38.30M | -50.07% |
Dec 31, 2024 | 76.70M | 46.65% |
Dec 29, 2023 | 52.30M | -83.19% |
Dec 30, 2022 | 311.20M | -77.67% |
Dec 31, 2021 | 1.39B | -8.65% |
Dec 31, 2020 | 1.53B | 71.04% |
Dec 31, 2019 | 891.90M | -43.76% |
Dec 31, 2018 | 1.59B | 186.35% |
Dec 29, 2017 | 553.80M | 35.14% |
Dec 30, 2016 | 409.80M | -45.80% |
Dec 31, 2015 | 756.10M | 39.84% |
Dec 31, 2014 | 540.70M | 151.14% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |